drug protocol number

CYTB323L12201

drug sponsor

Novartis /ArabMed

drug study

Rapcabtagene autoleucel (YTB323)

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase